abstract |
The present invention relates to a stable pharmaceutical composition containing at least a thienopyridine derivative acid salt as the active ingredient, namely 5-(2-chrobenzyl)-4,5,6,7-tetrahydrothienoÄ3, 2-cÜ-pyridine hydrochloride, and an excipient not including the active ingredient degradation. |